Clinical Trial Update: GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating GAPP induction and concurrent chemoradiotherapy followed by toripalimab maintenance for nasopharyngeal carcinoma. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: RECRUITING